185 related articles for article (PubMed ID: 32757049)
1. Effect of high-fat diet on the pharmacokinetics and safety of flumatinib in healthy Chinese subjects.
Kuang Y; Song HL; Yang GP; Pei Q; Yang XY; Ye L; Yang S; Wu ST; Guo C; He QN; Huang J
Cancer Chemother Pharmacol; 2020 Sep; 86(3):339-346. PubMed ID: 32757049
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability.
Li H; Wei Y; Zhang S; Xu L; Jiang J; Qiu Y; Mangin E; Zhao XM; Xie S
Clin Drug Investig; 2019 Nov; 39(11):1109-1116. PubMed ID: 31432392
[TBL] [Abstract][Full Text] [Related]
3. Effect of High-Fat Meal on the Pharmacokinetics and Safety of Valsartan/Amlodipine Fixed Dose Combination Tablets in Healthy Subjects.
Song H; Qiu B; Sun X; Guo C; Hu Y; Bai W; Dong Z
Drug Des Devel Ther; 2024; 18():43-51. PubMed ID: 38225972
[TBL] [Abstract][Full Text] [Related]
4. Effect of Food (Low and High Fat) on Pharmacokinetics of FCN-159, a Selective MEK Inhibitor, in Healthy Chinese Males.
Li J; Tan Y; Li K; Hui AM; Wu Z; Han P; Wei Z; Qiu J; Diao L; Wang X
Adv Ther; 2023 Mar; 40(3):1074-1086. PubMed ID: 36627544
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study.
Li X; Wang C; Li T; Liu Y; Liu S; Tao Y; Ma Y; Gao X; Cao Y
BMC Pharmacol Toxicol; 2020 Nov; 21(1):80. PubMed ID: 33213527
[TBL] [Abstract][Full Text] [Related]
6. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of single- and multiple-dose flumatinib in patients with chronic phase chronic myeloid leukemia.
Jiang B; Qi J; Sun M; Zheng W; Wei Y; Wang J; Zhang F
Front Oncol; 2023; 13():1101738. PubMed ID: 36814813
[TBL] [Abstract][Full Text] [Related]
8. Effect of a High-Fat Diet on the Pharmacokinetics and Safety of Rivaroxaban in Healthy Chinese Subjects.
Sun X; Song H; Liu H; Qiu B; Ding C; Hu Y; Bai W; Dong Z
Clin Pharmacol Drug Dev; 2024 Feb; 13(2):146-151. PubMed ID: 37740607
[TBL] [Abstract][Full Text] [Related]
9. The effect of food on the pharmacokinetics of Sutetinib maleate capsule, an irreversible EGFR tyrosine kinase inhibitor, in healthy Chinese subjects.
Cao B; Ma T; Zhang Y; Huang L; Lin H; Jiang H; Zhao Y; Geng Y; Yang Y; Cao S; Li J
Invest New Drugs; 2024 Jun; 42(3):289-298. PubMed ID: 38602625
[TBL] [Abstract][Full Text] [Related]
10. Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects.
Wu J; Xu H; Li H; Ma L; Chen J; Yuan F; Sheng L; Liu C; Chen W; Li X
Drug Des Devel Ther; 2023; 17():761-769. PubMed ID: 36925997
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
Sikes C; Stark JG; McMahen R; Engelking D
Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
Li W; Wang Y; Pei Y; Xia Y
Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects.
Wang J; Zhang H; Wang R; Cai Y
Drug Des Devel Ther; 2021; 15():1181-1193. PubMed ID: 33758499
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and Bioequivalence of 2 Immediate-Release Tofacitinib Tablet Formulations in Chinese Healthy Volunteers Under Fasting and Fed Conditions.
Li X; Liu L; Deng Y; Li Y; Zhang P; Wang Y; Xu B; Feng J; Huang L
Clin Pharmacol Drug Dev; 2021 May; 10(5):535-541. PubMed ID: 32770665
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects.
Xu M; Ni Y; Zhou Y; He X; Li H; Chen H; Li W
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):541-8. PubMed ID: 26294172
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study.
Wang CJ; Li T; Lin PP; Tao Y; Jiang X; Li X; Wen Q; Cao Y
Adv Ther; 2021 Sep; 38(9):4798-4814. PubMed ID: 34347254
[TBL] [Abstract][Full Text] [Related]
17. Effects of diet and gender on the pharmacokinetics of oral lenvatinib: A clinical trial in healthy Chinese participants.
Wei Y; Yu Y; Zhang W; Mu H; He K; Wen Q; Zhang X
Int J Clin Pharmacol Ther; 2023 Nov; 61(11):475-481. PubMed ID: 37644876
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
[TBL] [Abstract][Full Text] [Related]
19. Effect of High-Fat Food on the Pharmacokinetic Profile and Safety of SAF-189s, an ALK/ROS1 Inhibitor, in Healthy Chinese Adults.
Qin H; Tan Y; Diao L; Hui AM; Wu Z; Zhou Y; Sun J; Xiang X; Qiu J; Hu W
Drugs R D; 2023 Dec; 23(4):465-473. PubMed ID: 37934354
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical trial of HC-1119 soft capsule in Chinese healthy adult male subjects: Pharmacokinetics and safety of single-dose proportionality and effects of food.
Ma H; Xu W; Ni J; Zhao N; Tang S; Li S; Cai T; Xiu J; Kang X; Gao S; Zhang L; Zhou T
Prostate; 2022 Feb; 82(2):276-285. PubMed ID: 34807458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
